(19)
(11) EP 1 399 584 A2

(12)

(88) Date of publication A3:
31.12.2003

(43) Date of publication:
24.03.2004 Bulletin 2004/13

(21) Application number: 01981443.3

(22) Date of filing: 11.10.2001
(51) International Patent Classification (IPC)7C12Q 1/68
(86) International application number:
PCT/US2001/031607
(87) International publication number:
WO 2002/031198 (18.04.2002 Gazette 2002/16)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 11.10.2000 US 239294 P
11.10.2000 US 239297 P
11.10.2000 US 239605 P
12.10.2000 US 239802 P
12.10.2000 US 239805 P
12.10.2000 US 239806 P
16.10.2000 US 240622 P
19.10.2000 US 241723 P
19.10.2000 US 241682 P
31.10.2000 US 244932 P

(71) Applicant: Avalon Pharmaceuticals
Gaithersburg, MD 20878 (US)

(72) Inventors:
  • YOUNG, Paul, E.
    Gaithersburg, MD 20870 (US)
  • HORRIGAN, Stephen
    Potomac, MD 20854 (US)
  • WEAVER, Zoe
    Chevy Chase, MD 20815 (US)
  • ENDRESS, Gregory, A.
    Florence, MA 01062 (US)

(74) Representative: Ruffles, Graham Keith et al
Marks & Clerk,66-68 Hills Road
Cambridge,Cambridgeshire CB2 1LA
Cambridge,Cambridgeshire CB2 1LA (GB)

   


(54) CANCER-LINKED GENES AS TARGETS FOR CHEMOTHERAPY